Prime Medicine PRME Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | $838K-31.6% | $1.23M+9.9% | $1.12M-23.3% | $1.45M-33.4% | ||
| $34.11M-1.7% | $34.71M-21.1% | $43.99M+6.3% | $41.38M+2.0% | $40.56M+18.9% | ||
| $17.41M+18.1% | $14.74M+31.5% | $11.21M-14.6% | $13.12M-1.3% | $13.28M+8.0% | ||
| $51.51M+4.2% | $49.45M-10.4% | $55.2M+1.3% | $54.49M+1.2% | $53.85M+16.0% | ||
| -$50.65M-4.2% | -$48.61M+9.9% | -$53.97M-1.1% | -$53.38M-1.9% | -$52.39M-18.5% | ||
| $1.53M-39.4% | $2.53M-25.4% | $3.39M+331% | $786K+56.6% | $502K-74.2% | ||
| -$49.12M-6.6% | -$46.08M+8.9% | -$50.58M+3.8% | -$52.59M-1.4% | -$51.89M-22.7% | ||
| -$0.28-16.7% | -$0.24+25.0% | -$0.32+22.0% | -$0.41-2.5% | -$0.40-29.0% | ||
| -$48.8M-4.4% | -$46.73M+10.3% | -$52.09M-1.1% | -$51.51M-1.6% | -$50.69M-19.3% | ||
| -$50.65M-4.2% | -$48.61M+9.9% | -$53.97M-1.1% | -$53.38M-1.9% | -$52.39M-18.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Prime Medicine's revenue?
- Prime Medicine (PRME) generated $4.6M in revenue over the trailing twelve months, up 55.3% year over year.
- Is Prime Medicine profitable?
- Prime Medicine is not currently profitable: it reported a net loss of $198.4M over the trailing twelve months, a -4342.4% net margin.
- What is Prime Medicine's earnings per share?
- Prime Medicine's diluted EPS over the trailing twelve months is $-1.25.
- Where does Prime Medicine's income statement data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
